Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W P Bowman

Showing results (41-50 of 61) with videos related to

Pageof 7
Sort By:
The New England Journal of Medicine|February 20, 1986
Clinical pharmacodynamics of high-dose methotrexate in acute lymphocytic leukemia. Identification of a relation between concentration and effectW E Evans, W R Crom, M Abromowitch, et al.
Journal of Pediatric Hematology/Oncology|January 1, 1997
Idarubicin and cytosine arabinoside reinduction therapy for children with multiple recurrent or refractory acute lymphoblastic leukemia: a Pediatric Oncology Group studyM L Bernstein, T C Abshire, B H Pollock, et al.
Medical and Pediatric Oncology|January 1, 1982
VM-26 with prednisone and vincristine for treatment of refractory acute lymphocytic leukemiaG Rivera, W P Bowman, S B Murphy, et al.
Medical and Pediatric Oncology|October 23, 1997
Fractionated cylophosphamide and back to back high dose methotrexate and cytosine arabinoside improves outcome in patients with stage III high grade small non-cleaved cell lymphomas (SNCCL): a randomized trial of the Pediatric Oncology GroupM L Brecher, M R Schwenn, M J Coppes, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1996
Improved survival for children with B-cell acute lymphoblastic leukemia and stage IV small noncleaved-cell lymphoma: a pediatric oncology group studyW P Bowman, J J Shuster, B Cook, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 25, 2000
Universal inactivation of both p16 and p15 but not downstream components is an essential event in the pathogenesis of T-cell acute lymphoblastic leukemiaM Omura-Minamisawa, M B Diccianni, A Batova, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1985
Clinical relevance of lymphoblast biological features in children with acute lymphoblastic leukemiaD K Kalwinsky, P Roberson, G Dahl, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1994
Phase I trial of continuous infusion carboplatin and etoposide in children with refractory acute leukemia: a Pediatric Oncology Group studyP D Sadowitz, R Dubowy, A Souid, et al.
Blood|October 1, 1985
Serum lactic dehydrogenase level has prognostic value in childhood acute lymphoblastic leukemiaC H Pui, R K Dodge, G V Dahl, et al.
Blood|October 1, 1982
Prognostic importance of chromosome number in 136 untreated children with acute lymphoblastic leukemiaD L Williams, A Tsiatis, G M Brodeur, et al.
Pageof 7

Showing results (41-50 of 61) with videos related to

Sort By:
Pageof 7
The New England Journal of Medicine|February 20, 1986
Clinical pharmacodynamics of high-dose methotrexate in acute lymphocytic leukemia. Identification of a relation between concentration and effectW E Evans, W R Crom, M Abromowitch, et al.
Journal of Pediatric Hematology/Oncology|January 1, 1997
Idarubicin and cytosine arabinoside reinduction therapy for children with multiple recurrent or refractory acute lymphoblastic leukemia: a Pediatric Oncology Group studyM L Bernstein, T C Abshire, B H Pollock, et al.
Medical and Pediatric Oncology|January 1, 1982
VM-26 with prednisone and vincristine for treatment of refractory acute lymphocytic leukemiaG Rivera, W P Bowman, S B Murphy, et al.
Medical and Pediatric Oncology|October 23, 1997
Fractionated cylophosphamide and back to back high dose methotrexate and cytosine arabinoside improves outcome in patients with stage III high grade small non-cleaved cell lymphomas (SNCCL): a randomized trial of the Pediatric Oncology GroupM L Brecher, M R Schwenn, M J Coppes, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1996
Improved survival for children with B-cell acute lymphoblastic leukemia and stage IV small noncleaved-cell lymphoma: a pediatric oncology group studyW P Bowman, J J Shuster, B Cook, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 25, 2000
Universal inactivation of both p16 and p15 but not downstream components is an essential event in the pathogenesis of T-cell acute lymphoblastic leukemiaM Omura-Minamisawa, M B Diccianni, A Batova, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1985
Clinical relevance of lymphoblast biological features in children with acute lymphoblastic leukemiaD K Kalwinsky, P Roberson, G Dahl, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1994
Phase I trial of continuous infusion carboplatin and etoposide in children with refractory acute leukemia: a Pediatric Oncology Group studyP D Sadowitz, R Dubowy, A Souid, et al.
Blood|October 1, 1985
Serum lactic dehydrogenase level has prognostic value in childhood acute lymphoblastic leukemiaC H Pui, R K Dodge, G V Dahl, et al.
Blood|October 1, 1982
Prognostic importance of chromosome number in 136 untreated children with acute lymphoblastic leukemiaD L Williams, A Tsiatis, G M Brodeur, et al.
Pageof 7